P2 PURINERGIC RECEPTORS IN PANCREATIC DUCTAL ADENOCARCINOMA AS THERAPEUTIC TARGETS

$776,831FY2025Defense Health AgencyDOD

The Johns Hopkins University

Investigators

P2 PURINERGIC RECEPTORS IN PANCREATIC DUCTAL ADENOCARCINOMA AS THERAPEUTIC TARGETS · GrantIndex